Blood-Based Biomarkers for Alzheimer Disease: Preventing Unintended Consequences
Date
2026
Language
American English
Embargo Lift Date
Department
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
American Medical Association
Can't use the file because of accessibility barriers? Contact us with the title of the item, permanent link, and specifics of your accommodation need.
Abstract
This Viewpoint discusses areas of potential harm and actions needed to mitigate risk so that the use of blood-based biomarkers for Alzheimer disease can achieve the intended goal of improving care for all.
Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Whitson HE, Fowler NR, Mielke MM. Blood-Based Biomarkers for Alzheimer Disease: Preventing Unintended Consequences. JAMA. 2026;335(8):663-664. doi:10.1001/jama.2025.26049
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
JAMA
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
Version
Author's manuscript